Barcode Five Rights System



Use Barcode to prevent medication errors



ADERS ® is a barcode point of care, (BPOC), solution

Request Info











Practical Compliance Solutions, Corp. helps care facilities reduce risk at the patient's bedside. Our five rights barcode solution is the easiest to implement. Our barcode point of care system can help prevent medication errors in hospitals, long term care facilities, and assisted living communities.

ADERS ® is our barcode solution for the healthcare industry. It helps eliminate medication errors by allowing caregivers to scan NDC barcodes at the patient's bedside, verifying right patient, right drug, right time, right dose, and right route of administration. For more information click the products menu or send us a web request from our Contact menu. Ask for a DEMO CD. It is the full product that is licensed for an evaluation period.

We are offering a 30 day no-obligation free trial of the ADERS ® software. Care facilities can easily determine if ADERS ® is right for them by using the software as a pilot for a single unit or ward. Click here to download a Microsoft Project plan showing how you can implement a five rights point of care barcode pilot in less than a week. If you Don't own MS Project 2003, then here is a PDF copy just to see.... Download Adobe PDF Data Sheet

View a PowerPoint Presentation of ADERS ®.





Current Patient Safety and Drug Safety Updates from the FDA


FDA Press Releases RSS Feed

FDA Roundup: June 6, 2023
Tue, 06 Jun 2023 15:43:17 EDT

  The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

FDA Permits Marketing of First COVID-19 At-Home Test Using Traditional Premarket Review Process
Tue, 06 Jun 2023 15:02:58 EDT

  The U.S. Food and Drug Administration granted marketing authorization for the Cue COVID-19 Molecular Test.

FDA Announces Additional Steps to Modernize Clinical Trials
Tue, 06 Jun 2023 10:06:08 EDT

  The FDA is announcing the availability of a draft guidance with updated recommendations for good clinical practices aimed at modernizing the design and conduct of clinical trials.

FDA Roundup: June 2, 2023
Fri, 02 Jun 2023 15:45:56 EDT

  The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

FDA Conducts Retailer Inspection Blitz, Cracks Down on Illegal Sales of Popular Disposable E-cigarettes
Wed, 31 May 2023 10:20:58 EDT

  The FDA issued warning letters to 29 retailers, and one distributor, for illegally selling unauthorized tobacco products, specifically types of Puff and Hyde disposable e-cigarettes.

FDA Roundup: May 30, 2023
Tue, 30 May 2023 16:02:55 EDT

  The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

FDA Proposes New, Easy-to-Read Medication Guide for Patients, Patient Medication Information
Tue, 30 May 2023 11:40:32 EDT

  The FDA proposed a new, easy-to-read Medication Guide for patients. Patient Medication Information would provide patients with clear, concise, accessible and useful written information for prescription drugs and certain biological products would be delivered in a consistent and easy-to-understand fo

FDA Roundup: May 26, 2023
Fri, 26 May 2023 15:09:11 EDT

  The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

FDA Approves First Oral Antiviral for Treatment of COVID-19 in Adults
Thu, 25 May 2023 09:56:49 EDT

  The FDA approved oral antiviral Paxlovid for the treatment of mild-to-moderate COVID-19 in adults who are at high risk for progression to severe COVID-19, including hospitalization or death.

FDA Approves New Treatment for Pneumonia Caused by Certain Difficult-to-Treat Bacteria
Tue, 23 May 2023 17:16:21 EDT

  FDA approved Xacduro, a new treatment for hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia caused by susceptible strains of bacteria called Acinetobacter baumannii-calcoaceticus complex, for patients 18 years of age and older.

FDA Roundup: May 23, 2023
Tue, 23 May 2023 16:04:34 EDT

  The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

FDA Approves New Buprenorphine Treatment Option for Opioid Use Disorder
Tue, 23 May 2023 15:32:53 EDT

  The U.S. Food and Drug Administration approved Brixadi (buprenorphine) extended-release injection for subcutaneous use to treat moderate to severe opioid use disorder (OUD)

FDA Approves Prescription Nasal Spray to Reverse Opioid Overdose
Mon, 22 May 2023 16:56:52 EDT

  The U.S. Food and Drug Administration approved Opvee, the first nalmefene hydrochloride nasal spray for the emergency treatment of known or suspected opioid overdose in adults and pediatric patients 12 years of age and older

FDA Roundup: May 19, 2023
Fri, 19 May 2023 15:31:46 EDT

  The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

FDA Approves First Topical Gene Therapy for Treatment of Wounds in Patients with Dystrophic Epidermolysis Bullosa
Fri, 19 May 2023 13:47:19 EDT

  FDA approves Vyjuvek, a herpes-simplex virus type 1 vector-based gene therapy, for the treatment of wounds in patients 6 months of age and older with dystrophic epidermolysis bullosa with mutation(s) in the collagen type VII alpha 1 chain gene.

FDA Clears New Insulin Pump and Algorithm-Based Software to Support Enhanced Automatic Insulin Delivery
Fri, 19 May 2023 11:32:59 EDT

  The U.S. Food and Drug Administration cleared devices that are part of the Beta Bionics iLet Bionic Pancreas System for people six years of age and older with type 1 diabetes

FDA Roundup: May 16, 2023
Tue, 16 May 2023 13:51:28 EDT

  The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

FDA Roundup: May 12, 2023
Fri, 12 May 2023 15:32:09 EDT

  The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

FDA Approves Novel Drug to Treat Moderate to Severe Hot Flashes Caused by Menopause
Fri, 12 May 2023 14:01:24 EDT

  The FDA approved Veozah (fezolinetant), an oral medication for the treatment of moderate to severe vasomotor symptoms, or hot flashes, caused by menopause. Veozah is the first neurokinin 3 receptor antagonist approved by the FDA to treat moderate to severe hot flashes from menopause.

FDA Approves First Drug to Treat Agitation Symptoms Associated with Dementia due to Alzheimer’s Disease
Thu, 11 May 2023 09:29:10 EDT

  The FDA granted supplemental approval to Rexulti (brexpiprazole) oral tablets for the treatment of agitation associated with dementia due to Alzheimer’s disease. This is the first FDA-approved treatment option for this indication.

Food and Drugs Administration--Recalls/Safety Alerts

Rudolph Foods Issues Allergy Alert on Undeclared Wheat in Rudolph’s OnYums “Onion Flavored Rings”, 3 oz. Packages
Wed, 31 May 2023 18:17:00 EDT

  Rudolph Foods is recalling 39 cases of Rudolph’s OnYums “Onion Flavored Rings” in 3 oz. packages, because they may contain undeclared wheat and other sensitive ingredients, including monosodium glutamate and artificial colors yellow 6, yellow 6 lake, blue 2 lake, blue 1 lake, and red 40 lake. People

Tillamook Issues Allergy Alert on Undeclared Wheat and Soy in Tillamook Waffle Cone Swirl Ice Cream Packaged in Chocolate Peanut Butter Ice Cream Carton
Wed, 31 May 2023 15:48:00 EDT

  Tillamook County Creamery Association is voluntarily recalling a limited quantity of family-size 1.5qt cartons of Tillamook Waffle Cone Swirl ice cream mistakenly packaged in a Tillamook Chocolate Peanut Butter ice cream carton, lot TL-41-80, BB041324, due to undeclared wheat and soy. The Waffle Con

Cricket Creek Farm Recalls Sophelise and Tobasi Cheeses Because of Potential Listeria Monocytogenes Contamination
Tue, 30 May 2023 17:14:00 EDT

  Cricket Creek Farm of Williamstown, MA is recalling 165 units of Sophelise cheese and 149 pounds of Tobasi cheese because it has the potential to be contaminated with Listeria monocytogenes, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people

A.S.K. Foods Inc. Issues Allergy Alert on Undeclared Milk In Wegmans Penne Rigate Mozzarella Salad
Fri, 26 May 2023 00:00:00 EDT

  A.S.K. Foods, Inc. of Palmyra, PA is voluntarily recalling select 30 oz. containers of Wegmans Penne Rigate Mozzarella Salad because it may contain undeclared milk. People who have an allergy or severe sensitivity to milk run the risk of serious or life-threatening allergic reaction if they consume

T.W. Garner Food Company Issues Voluntary Recall on Texas Pete® Buffalo Wing Sauce Due to Undeclared Soy
Thu, 25 May 2023 00:00:00 EDT

  T.W. Garner Food Company is voluntarily recalling 50,688 bottles of 12 oz. Texas Pete® Buffalo Wing Sauce with best used by 120623T 065239 UPC 0 75500 10011 6 because some of the bottles may contain Texas Pete® Extra Mild Wing Sauce which contains soy. People who have an allergy or severe sensitivit

Flowers Foods Issues Voluntary Recall on Tastykake Chocolate Kandy Kakes Due to Undeclared Peanuts
Wed, 24 May 2023 00:00:00 EDT

  Flowers Foods, Inc. (NYSE: FLO) is voluntarily recalling certain Tastykake® Chocolate Kandy Kakes due to undeclared peanuts. People who have an allergy or severe sensitivity to peanuts run the risk of serious or life-threatening allergic reaction if they consume this product. The product being recal

Meijer Issues Allergy Alert on Undeclared Milk in Frederik’s Dark Chocolate Almonds and Meijer Express Go Cup Dark Chocolate
Tue, 23 May 2023 15:24:00 EDT

  Meijer, in conjunction with its supplier, Lamontagne Chocolate Corp., is announcing a recall of Frederik’s Dark Chocolate Almonds and Meijer Express Go Cup Dark Chocolate Almonds because they may contain undeclared milk. People who have an allergy or severe sensitivity to milk run the risk of a seri

Van Leeuwen Issues Voluntary Recall on Undeclared Walnuts in its Brown Sugar Chunk Ice Cream Pints
Tue, 23 May 2023 14:41:00 EDT

  Van Leeuwen Ice Cream of Brooklyn, NY is voluntarily recalling 4,096 frozen 14 oz pints of its French Ice Cream product "Brown Sugar Chunk” because it contains an undeclared allergen, walnuts. People who have an allergy or severe sensitivity to walnuts run the risk of serious or life-threatening al

DIBE LLC Issues Allergy Alert on Undeclared Soy, Walnuts, and Wheat in “Tetas Mireya Sabor Nutella, Toddy, Ferrero, Galleta Maria & Galleta Oreo”
Mon, 22 May 2023 16:19:00 EDT

  DIBE LLC. of MIAMI, FL, is recalling its 6 ounces packages of "TETAS MIREYA SABOR NUTELLA, TODDY, FERRERO, GALLETA MARIA & GALLETA OREO " food popsicles because they may contain undeclared allergens:


Nature’s Energy Issues Allergy Alert on Undeclared Milk in Children’s Chewable Colostrum Products
Thu, 18 May 2023 18:00:00 EDT

  Nature’s Energy of Pleasant Grove, UT is voluntarily recalling Children’s Chewable Colostrum because it may contain undeclared milk allergen.

Werner Gourmet Meat Snacks Issues Allergy Alert on Undeclared Peanut in Chile Cacahuates Japones
Thu, 18 May 2023 18:00:00 EDT

  Werner Gourmet Meat Snacks in Tillamook, OR is voluntarily recalling 14,682 packages of Chile Cacahuates Japones, 5oz Value Size, because it may contain undeclared peanut.

Novis PR LLC Emite Retiro Voluntario de Gotas Pediátricas G-Supress DX Debido a Empaque Incorrecto
Thu, 18 May 2023 16:38:00 EDT

  San Juan, PR, Novis PR LLC está retirando voluntariamente el lote D20911 Exp 10/25 de gotas pediátricas G-Supress DX a nivel de consumidor. Se ha encontrado que algunas cajas del producto contienen un producto incorrecto en su interior. El producto incorrecto en el interior es un anestésico/analgési

Novis PR LLC Issues Voluntary Recall of G-Supress DX Pediatric Drops Due to Incorrect Packaging
Thu, 18 May 2023 16:12:00 EDT

  San Juan, PR, Novis PR LLC is voluntarily recalling Lot D20911 Exp 10/25 of G-Supress DX Pediatric Drops to the consumer level. Some cartons of the product have been found to contain incorrect product inside. Incorrect product inside is an anesthetic/analgesic and not a brand of Novis PR LLC.

Hu Products Issues Voluntary Allergy Alert on Undeclared Tree Nuts (Hazelnut, Cashew, and/or Almond) in Vanilla Crunch Dark Chocolate Bar Product in the U.S.
Thu, 18 May 2023 14:58:00 EDT

  Hu Products announced today a voluntary recall in the United States of a single production lot of Vanilla Crunch Dark Chocolate Bar product (2.1 oz bar) because some packages may potentially contain undeclared hazelnut, cashew, and/or almond that were inadvertently added to the product during manufa

LiDestri Food Co. Issues Allergy Alert on Undeclared Fish (Anchovy) In 24-Oz Jars of Wegman’s Italian Classics Diavolo Pasta Sauce
Wed, 17 May 2023 00:00:00 EDT

  LiDestri Foods is recalling 24-ounce jars of Wegman’s Italian Classics Diavolo pasta sauce, because it may contain undeclared fish (anchovy). People who have an allergy or severe sensitivity to anchovy run the risk of serious or life-threatening allergic reaction if they consume these products. The

Associated Wholesale Grocers, Inc. is Releasing this Notice Due to Recalled Infant Formula Being Distributed to its Nashville Division Retailers after the Initial Recall Notice was Published
Sat, 13 May 2023 00:00:00 EDT

  On March 17, 2023, the Perrigo Company issued a voluntary recall of certain lots of Gerber® Good Start® SootheProTM Powdered Infant Formula in the U.S., that were manufactured at the Company’s Gateway Eau Claire, Wisconsin manufacturing facility from January 02, 2023 to January 18, 2023. This produc

Lancaster Foods Updates Voluntary Recall of Various Expired Kale, Spinach and Collard Green Products Due to Potential Health Risk
Fri, 12 May 2023 11:31:00 EDT

  Lancaster Foods is voluntarily recalling a limited quantity of 3 brands of already-expired Robinson Fresh, Lancaster, and Giant brand Kale, Spinach and Collard Green products produced at the company’s Jessup, Maryland facility. This recall is due to a possible health risk from Listeria monocytogen

CORRECTION NOTICE: New Hampshire Laboratory Error Incorrectly Resulted in Recall of lēf Farms “Spice” Packaged Salad Greens: Recall Canceled
Thu, 11 May 2023 00:00:00 EDT

  – The New Hampshire Department of Health and Human Services (DHHS) has determined that a laboratory error incorrectly caused last week’s recall announcement concerning lēf Farms “Spice” Packaged Salad Greens. The products from lēf Farms are safe and the recall has been canceled. On May 5, a press

Recall Press Release: TW4115 Black Fungus (Nam Meo)
Thu, 11 May 2023 00:00:00 EDT

  AH USA GROUP INC. is recalling its TW4115 Black Fungus (Nam Meo) product due to possible contamination. The recall is being conducted in cooperation with the California Department of Public Health and is being taken as a precautionary measure to ensure the safety and health of our consumers.

BearCare Voluntarily Recalls Rechargeable Walnut Thermometer Due to the Potential for Skin Burns
Wed, 10 May 2023 00:00:00 EDT

  BearCare, Inc. is initiating a voluntary recall of its rechargeable Walnut Wearable Smart Thermometer (Walnut Thermometer) due to reports of injuries, including skin burns, by users. The Walnut Thermometer is an over-the-counter rechargeable device intended for continuous chest temperature monitorin

What's New: Drugs RSS Feed

What's New Related to Drugs
Tue, 06 Jun 2023 16:36:49 EDT

  Want to know what's new on drugs from FDA? This page provides quick links to the latest on a variety of topics including: drug approvals, safety warnings, drug shortages, etc.

FDA Roundup: June 6, 2023
Tue, 06 Jun 2023 15:43:17 EDT

  The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

Frequently requested or proactively posted compliance records
Tue, 06 Jun 2023 15:31:17 EDT

  Frequently requested inspection records of foreign pharmaceutical manufacturing facilities

Nonprescription Drugs Advisory Committee Roster
Tue, 06 Jun 2023 15:26:30 EDT

  This page contains the Nonprescription Drugs Advisory Committee Roster, which lists the current members and the current number of vacancies for the committee.

Herbal Doctor Remedies - 583205 - 10/04/2019
Tue, 06 Jun 2023 14:44:00 EDT

  CGMP/Finished Pharmaceuticals/Adulterated

Drugs@FDA Data Files
Tue, 06 Jun 2023 14:40:50 EDT

  Drugs@FDA Downloadable Data File in ZIP format, Data Definitions, and Entity Relationship Diagram (ERD)

CDER SBIA Chronicles
Tue, 06 Jun 2023 14:17:04 EDT

  FDA/CDER SBIA Chronicles, the bi-monthly newsletter of the CDER Small Business and Industry Assistance team, provides industry with useful information to assist in all aspects of drug marketing and regulation

BeSafeRx: Your Source for Online Pharmacy Information
Tue, 06 Jun 2023 14:08:22 EDT

  Explore FDA’s BeSafeRx campaign resources and tools so you can make safer, more informed decisions when purchasing prescription medicine from an online pharmacy.

Pharmaceutical Quality Resources
Tue, 06 Jun 2023 13:29:20 EDT

  FDA provides resources on pharmaceutical quality topics, including information on regulations, guidance documents, and compliance programs.

Natural Wonder Products Corp - 592699 - 09/23/2019
Tue, 06 Jun 2023 12:08:24 EDT

  New Animal Drug/Adulterated

GPT Pharmaceuticals Private Ltd - 590938 - 06/02/2023
Tue, 06 Jun 2023 11:52:59 EDT

  CGMP/Finished Pharmaceuticals/Adulterated

GPT Pharmaceuticals Private Ltd - 590938 - 12/17/2019
Tue, 06 Jun 2023 11:51:29 EDT

  CGMP/Finished Pharmaceuticals/Adulterated

Multimedia Education Materials
Tue, 06 Jun 2023 10:24:21 EDT

  FDA offers a variety of materials in multiple formats to help promote understanding of biosimilars and interchangeable products.

FDA Announces Additional Steps to Modernize Clinical Trials
Tue, 06 Jun 2023 10:06:08 EDT

  The FDA is announcing the availability of a draft guidance with updated recommendations for good clinical practices aimed at modernizing the design and conduct of clinical trials.

Mr. Lulu LLC - 650772 - 06/01/2023
Tue, 06 Jun 2023 09:20:06 EDT

  CGMP/Finished Pharmaceuticals/Adulterated

Mobeen Mazhar, M.D. - 660335 - 05/31/2023
Tue, 06 Jun 2023 09:20:05 EDT

  Investigational Device Exemptions (Clinical Investigator)


ImprimisRx NJ - 657453 - 05/26/2023
Tue, 06 Jun 2023 09:20:04 EDT

  Compounding Pharmacy/Adulterated Drug Products

RemedyRepack, Inc. - 649198 - 05/11/2023
Tue, 06 Jun 2023 09:20:02 EDT

  CGMP/Finished Pharmaceuticals/Adulterated

E6(R3) GOOD CLINICAL PRACTICE (GCP)
Tue, 06 Jun 2023 08:45:07 EDT

  E6(R3) GOOD CLINICAL PRACTICE (GCP)

Newly Added Guidance Documents
Tue, 06 Jun 2023 08:45:01 EDT

  Guidance documents represent the FDA's current thinking on a particular subject. New guidance documents are listed here for three months.

Whats New Vaccines Blood Biologics RSS Feed

FDA Roundup: June 6, 2023
Tue, 06 Jun 2023 15:43:17 EDT

  The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

Drugs@FDA Data Files
Tue, 06 Jun 2023 14:40:50 EDT

  Drugs@FDA Downloadable Data File in ZIP format, Data Definitions, and Entity Relationship Diagram (ERD)

Coronavirus (COVID-19) | CBER-Regulated Biologics
Tue, 06 Jun 2023 12:57:35 EDT

  This page and the associated links provide information on guidance and advice relevant to the development of therapies to treat or prevent COVID-19, and contact information for developers seeking additional information or assistance.

Family Fertility Center - 588805 - 05/11/2020
Tue, 06 Jun 2023 12:25:33 EDT

  Deviations/CFR/Regulations for Human Cells, Tissues & Cellular Products (HCT/Ps)

Family Fertility Center - 588805 - 09/30/2019
Tue, 06 Jun 2023 12:25:33 EDT

  Deviations/CFR/Regulations for Human Cells, Tissues & Cellular Products (HCT/Ps)


Pfizer-BioNTech COVID-19 Vaccines
Tue, 06 Jun 2023 12:06:52 EDT

  Information about Pfizer-BioNTech COVID-19 Vaccine, Bivalent. Updated, bivalent mRNA COVID-19 vaccine boosters are now FDA-authorized for all doses.

Moderna COVID-19 Vaccines
Tue, 06 Jun 2023 12:00:03 EDT

  Information about Moderna COVID-19 Vaccine, Bivalent. Updated, bivalent mRNA COVID-19 vaccines are now FDA-authorized for all doses for individuals ages 6 months and older.

Novavax COVID-19 Vaccine, Adjuvanted
Tue, 06 Jun 2023 11:54:09 EDT

  Novavax COVID-19 Vaccine, Adjuvanted

Blood Products Advisory Committee April 26, 2023 Meeting Announcement - 04/26/2023
Tue, 06 Jun 2023 11:52:51 EDT

  This is the main page for the Blood Products Advisory Committee April 26, 2023 Meeting Announcement and meeting materials.

What’s New for Biologics
Tue, 06 Jun 2023 11:38:15 EDT

  Latest news from the Center for Biologics Evaluation and Research

Jobs at the Center for Biologics Evaluation and Research (CBER)
Tue, 06 Jun 2023 11:34:58 EDT

  CBER has unique opportunities for individuals with backgrounds in science or administration to fill positions involved in the regulation and research of blood, vaccines and therapeutics.

FDA Announces Additional Steps to Modernize Clinical Trials
Tue, 06 Jun 2023 10:06:08 EDT

  The FDA is announcing the availability of a draft guidance with updated recommendations for good clinical practices aimed at modernizing the design and conduct of clinical trials.

Roster of the Vaccines and Related Biological Products Advisory Committee
Mon, 05 Jun 2023 09:02:29 EDT

  This is the Roster of the Vaccines and Related Biological Products Advisory Committee

Antimicrobial Resistance Information from FDA
Mon, 05 Jun 2023 08:22:14 EDT

  Antimicrobial resistance (AMR)—the ability of a microorganism (bacteria, virus, fungi, parasite) to resist the effects of a drug—is a serious, complex and costly public health problem. Learn what FDA is doing to address AMR.

COVID-19 Vaccines
Fri, 02 Jun 2023 16:12:23 EDT

  FDA has rigorous scientific and regulatory processes in place to facilitate development and ensure the safety, effectiveness and quality of COVID-19 vaccines.

Biologics PREA Reviews and Labeling Changes
Fri, 02 Jun 2023 16:11:35 EDT

  PREA Labeling Changes, Medical, Statistical, and Clinical Pharmacology Reviews of Pediatric Studies Conducted under Section 505B of the Federal Food, Drug, and Cosmetic Act (the Act), as amended by the FDA Amendments Act of 2007 (FDAAA). These assessments are for CBER regulated drugs approved under section 505 of the Act and biological drugs licensed under section 351 of the Public Health Service Act.

Biologics Electronic Reading Room (eFOI)
Fri, 02 Jun 2023 16:04:46 EDT

  The Biologics eFOI Reading Room provides access to documents posted throughout the "Vaccines, Blood & Biologics" and other sections related to the Center for Biologics Evaluation and Research on the FDA.gov Web site.

PREVNAR 20
Fri, 02 Jun 2023 15:49:16 EDT

  Indication: Active immunization for the prevention of pneumonia and invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 8, 9V, 10A, 11A, 12F,14, 15B, 18C, 19A, 19F, 22F, 23F and 33F in adults 18 years of age and older.

FDA Roundup: June 2, 2023
Fri, 02 Jun 2023 15:45:56 EDT

  The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

Janssen COVID-19 Vaccine
Fri, 02 Jun 2023 14:46:44 EDT

  Information about the Janssen COVID-19 Vaccine, manufactured by Janssen Biotech Inc., a Janssen Pharmaceutical Company of Johnson & Johnson





See how to prevent medication errors with bar codes using ADERS. Get your free pilot started today.






Products



 
 

Services




Contact Us


About PCS


Corporate Headquarters


Practical Compliance Solutions
One Orient Way
Suite F156
Rutherford, NJ 07070
  201-728-8809


40.827731 N 74.101029 W

Connect With Us

   
 
 
© 2002 - 2023 - Copyright Practical Compliance Solutions - All rights reserved